THE RADIOLOGICAL SEQUELAE OF PULMONARY AND PLEURAL TUBERCULOSIS IN TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.4238/59x85m84Keywords:
Bronchiectasis, Fibrosis, Pleural diseases, Tuberculosis, Tuberculosis, pulmonary.Abstract
Objective: To determine the frequency and pattern of radiological sequelae of pulmonary and pleural tuberculosis in patients presenting to a tertiary care hospital.
Study Design: Cross-sectional study.
Duration and Place of Study: Conducted from 10 April to 30 June 2026 at the Pulmonology Unit, Ayub Teaching Hospital Abbottabad.
Methodology: A total of 93 patients with previous history of pulmonary or pleural tuberculosis were included by using prevalence-based sample size calculation. Patients who completed full anti-tuberculosis therapy and had post-treatment radiological findings on chest X-ray or high-resolution computed tomography were enrolled. Radiological sequelae including fibrosis, bronchiectasis, cavitation, pleural thickening and fibrosing mediastinitis were assessed according to radiologist report. Chi-square test and Fisher exact test were applied for post-stratification analysis.
Results: Mean age of patients was 49.39 ± 19.40 years and mean duration after anti-tuberculosis therapy was 8.66 ± 5.61 years. Male patients were 53 (57.0%) and rural residents were 66 (71.0%). Radiological sequelae were present in 73 (78.5%) patients. Fibrosis was the most common finding observed in 63 (86.3%) patients, followed by bronchiectasis in 31 (42.5%), pleural thickening in 19 (26.0%), cavitation in 14 (19.2%) and fibrosing mediastinitis in 1 (1.4%) patient. Age above 50 years (p=0.022) and rural residence (p=0.004) showed significant association with radiological sequelae.
Conclusion: Radiological sequelae after tuberculosis were very common, with fibrosis being the predominant finding. Older age and rural residence were significantly associated with higher frequency of sequelae.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

